70 related articles for article (PubMed ID: 2959574)
41. [Treatment of psoriasis vulgaris with Hoepixin-bath].
Holzegel K; Loertzer HJ
Z Arztl Fortbild (Jena); 1973 Oct; 67(20):1062-3. PubMed ID: 4774653
[No Abstract] [Full Text] [Related]
42. Quantitative studies on the reactions of psoriatic epidermis to treatment.
McMinn RM; Woods MS; Fry L
Acta Derm Venereol; 1980; 60(6):491-4. PubMed ID: 6162333
[TBL] [Abstract][Full Text] [Related]
43. Isoquinoline is a possible anti-psoriatic agent in coal tar.
Foreman MI; Taylor M; Clark C; Devitt H; Hanlon G; Kelly I; Lukowiecki G
Br J Dermatol; 1985 Mar; 112(3):323-8. PubMed ID: 2579670
[TBL] [Abstract][Full Text] [Related]
44. Holistic development of coal tar lotion by embedding design of experiments (DoE) technique: preclinical investigations.
Sharma M; Sharma G; Singh B; Dhiman V; Bhadada SK; Katare OP
Expert Opin Drug Deliv; 2020 Feb; 17(2):255-273. PubMed ID: 31990219
[No Abstract] [Full Text] [Related]
45. Scanning electron microscope histochemistry: the use of backscattered electrons to identify epidermal Langerhans cells in the scanning electron microscope.
Newcomb GM; Boyde A
Histochem J; 1980 Nov; 12(6):695-700. PubMed ID: 6449492
[TBL] [Abstract][Full Text] [Related]
46. Antioxidant and prooxidant effects of the antipsoriatic compound anthralin in skin and subcellular fractions.
Fuchs J; Nitschmann W; Packer L
Adv Exp Med Biol; 1990; 264():537-41. PubMed ID: 2244537
[No Abstract] [Full Text] [Related]
47. [Effects of glucocorticosteroids on ocular surface Langerhans cells].
Tagawa Y; Takeuchi T; Saito M; Saga T; Matsuda H
Nippon Ganka Gakkai Zasshi; 1983; 87(10):927-34. PubMed ID: 6231846
[No Abstract] [Full Text] [Related]
48. Influence of storage conditions on the stability of anthralin in the presence of coal tar and salicylic acid in a white soft paraffin base.
Herman J; Remon JP; De Bersagues J
J Am Acad Dermatol; 1988 Apr; 18(4 Pt 1):750-1. PubMed ID: 3372769
[No Abstract] [Full Text] [Related]
49. Reduction in murine Langerhans cell ATPase staining following topical but not systemic treatment with steroid and non-steroid immunosuppressants.
Halliday GM; Knight BA; Muller HK
Br J Dermatol; 1986 Jan; 114(1):83-9. PubMed ID: 2935180
[TBL] [Abstract][Full Text] [Related]
50. Active oxygen species and structure specificity of antipsoriatic anthrones.
Müller K
Arch Pharm (Weinheim); 1988 Jul; 321(7):385-9. PubMed ID: 3219054
[No Abstract] [Full Text] [Related]
51. PSORIASIS: RESPONSE TO TOPICAL THERAPY.
FINKLER B
Skin (Los Angeles); 1963 Aug; 2():255-8. PubMed ID: 14064462
[No Abstract] [Full Text] [Related]
52. [Experiences in half-side treatment with tar additive to cignolin-salicylic-acid-white-vaseline therapy of psoriasis vulgaris].
Schulze HJ; Steigleder GK
Z Hautkr; 1984 May; 59(10):654-6. PubMed ID: 6741204
[TBL] [Abstract][Full Text] [Related]
53. Topical psoriasis therapy.
Federman DG; Froelich CW; Kirsner RS
Am Fam Physician; 1999 Feb; 59(4):957-62, 964. PubMed ID: 10068717
[TBL] [Abstract][Full Text] [Related]
54. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication no. 6: do treatments available for psoriasis patients carry a genetic or carcinogenic risk?
Mutat Res; 1981 May; 86(3):279-304. PubMed ID: 7029262
[No Abstract] [Full Text] [Related]
55. [Effect of topical antipsoriatic agents on ATPase-positive epidermal Langerhans cells. Animal experiment studies].
Gruner S; Strunk D; Diezel W
Dermatol Monatsschr; 1987; 173(8):436-40. PubMed ID: 2959574
[No Abstract] [Full Text] [Related]
56. The influence of topical dermatological treatment modalities on epidermal Langerhans cells and contact sensitization in mice.
Gruner S; Zwirner A; Strunk D; Sönnichsen N
Contact Dermatitis; 1992 Apr; 26(4):241-7. PubMed ID: 1395561
[TBL] [Abstract][Full Text] [Related]
57. [The effect of Tomesa therapy on epidermal Langerhans cells in experimental animals].
Gruner S; Zwirner A; Diezel W; Boonen H; Sönnichsen N
Dermatol Monatsschr; 1990; 176(7):399-402. PubMed ID: 2147911
[TBL] [Abstract][Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
